lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunsuppressive - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
teofyllin aurora medical 200 mg
2care4 aps - teofyllin - depottablett - 200 mg
teofyllin aurora medical 300 mg
2care4 aps - teofyllin - depottablett - 300 mg
laksekalsitonin aurora medical 100 ie/ ml
2care4 aps - laksekalsitonin - injeksjons-/infusjonsvæske, oppløsning - 100 ie/ ml
laksekalsitonin aurora medical 100 ie/ ml
2care4 aps - laksekalsitonin - injeksjons-/infusjonsvæske, oppløsning - 100 ie/ ml
kloramfenikol aurora medical 10 mg/ g
2care4 aps - kloramfenikol - Øyesalve - 10 mg/ g
metylfenidat aurora medical 10 mg
2care4 - metylfenidathydroklorid - tablett - 10 mg
permetrin aurora medical 5 %
2care4 aps - permetrin - krem - 5 %
tiamin aurora medical 50 mg/ ml
2care4 aps - tiaminhydroklorid - injeksjonsvæske, oppløsning - 50 mg/ ml
kolkisin aurora medical 500 mikrog
2care4 - kolkisin - tablett - 500 mikrog